NCT05952934 2026-04-08
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
University of Arkansas
Phase 2 Recruiting
Clinical Trials
9 trialsNCT05952804 2026-04-02
IVIG for Infection Prevention After CAR-T-Cell Therapy
Fred Hutchinson Cancer Center
Phase 2 Recruiting
NCT06634030 2026-03-23
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
Vanderbilt University Medical Center
Phase 2 Recruiting
NCT04899908 2026-03-19
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Brigham and Women's Hospital
Phase 2 Active not recruiting
NCT05849129 2026-01-23
AIVAA
The Canadian College of Naturopathic Medicine
Phase 2 Recruiting
NCT06067438 2025-09-23
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT02134925 2025-09-10
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04761822 2025-08-12
SARS
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT01059786 2025-06-12
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting